|
Medical Director, TGH Cancer Institute Dr. Thomas J. Rutherford is the medical director of the Tampa General Hospital Cancer Institute and director of the Division of Gynecology and Oncology at the USF Health Morsani College of Medicine. He approaches patient care as an advocate for total cancer care, recognizing that patient care encompasses a continuum from prevention and high-risk genetic screening to individualized treatment, survivorship and end-of-life care. A nationally recognized surgeon, Dr. Rutherford came to Tampa from Western Connecticut Health Network, where he was the network physician director of cancer services. Before that, he was a professor, division director of gynecologic oncology and director of the gynecologic oncology fellowship at the Yale University School of Medicine. Dr. Rutherford has authored more than 100 scientific journal articles on the prevention, early detection and treatment of gynecological cancers. |
 |
Matthew L. Anderson, MD, PhD, PACOG Gynecologic Oncologist, Tampa General Hospital Dr. Matthew L. Anderson specializes in the surgical and medical management of pre-malignant and malignant diseases of the female reproductive tract. He utilizes state-of-the-art approaches, including both minimally invasive and robotic surgery, to achieve the best possible clinical outcomes in a friendly, patient-oriented environment. Dr. Anderson leverages his unique expertise as a nationally recognized translational cancer researcher to help his patients gain a better understanding of their disease and personalize the therapeutic approach. His experience with genetics is particularly helpful for patients seeking options for managing an inherited predisposition to ovarian and/or uterine cancer. In addition, Dr. Anderson’s many years of experience as a surgeon allow him to effectively address complex gynecologic issues, such as large pelvic masses, fistulas and difficult cases of endometriosis and uterine leiomyomas. |
 |
Gynecologic Oncologist, Tampa General Hospital Dr. Adrian Kohut is a board-certified OB-GYN with sub-specialty training in Gynecologic Oncology. During medical school, Dr. Kohut developed a strong interest in Gynecologic Oncology and thus went on to complete residency training in Obstetrics and Gynecology at Rutgers Robert Wood Johnson Medical School in 2019, followed by an Advanced Pelvic Surgery fellowship at Emory University School of Medicine in 2020 and a Gynecologic Oncology fellowship at City of Hope Comprehensive Cancer Center in 2023. Dr. Kohut is passionate about advancing the care of women diagnosed with gynecologic malignancies, as well as those with complex benign and pre-malignant gynecologic conditions. His clinical research interests include using predictive modeling for applications in surgical quality improvement and precision medicine and advancing the role of intraperitoneal drug delivery in peritoneal surface malignancies. Dr. Kohut’s translational research interests include targeting the JAK/STAT signaling pathway to overcome PARP inhibitor resistance and understanding the role of aberrant protein phosphatase activity in high-grade uterine cancer. |
